Essential Partners’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
Essential Partners's HLVX Position: Q3 2025 in Review
Essential Partners sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 12 shares — an estimated $24 sold.
Essential Partners first reported a position in HLVX in Q2 2025 and held it in 1 quarter. The position peaked at $24 in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.
- Essential Partners reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
- Essential Partners sold 12 HilleVax shares in Q3 2025, an estimated $24.
- Essential Partners first reported a position in HilleVax in Q2 2025 and held it in 1 quarter.
- Essential Partners's HilleVax position peaked at $24 in Q2 2025.
- 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.
Based on Essential Partners's 13F filing for Q3 2025, filed 21 May 2026.